Synedgen Research Results Demonstrate New Therapy for Cystic Fibrosis Patients – PRWeb

The poster, Novel Biopolymer SYN01 Potentiates Antibacterial Activity of Tobramycin, Dissolves P. aeruginosa Biofilms, and Reduces the Viscosity of Cystic Fibrosis Sputum, summarizes theses findings and demonstrates the potential impact of Syndegen’s …